The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer recognition and assessment through non-invasive evaluation (CRANE): A prospective clinical validation study of a multi-biomarker class multi-cancer early detection (MCED) test in Japan.
 
Takeaki Yamazaki
No Relationships to Disclose
 
Yoshiaki Nakamura
Consulting or Advisory Role - DAIICHI SANKYO Co., Ltd.; Exact Sciences; Gilead Sciences; Guardant Health Pte Ltd; Natera,Inc.; Premo Partners, Inc.; Roche Ltd./; Seagen,Inc.; Takeda
Speakers' Bureau - Becton Dickinson; CareNet,Inc.; Chugai Pharma; DAIICHI SANKYO Co., Ltd.; Eisai; Guardant Health Japan Corp.; Guardant Health Pte Ltd; Hisamitsu Pharmaceutical; Merck; Miyarisan pharmaceutical; MSD K.K; Taiho Pharmaceutical; Zeria Pharmaceutical
 
Mitsuho Imai
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - 10X Genomics; Caris Life Sciences; Chugai Pharma; Exact Sciences
Research Funding - Exact Sciences
Patents, Royalties, Other Intellectual Property - 1. ?NCC's Reference: #2023-03 Filing number (Filing date): US 63/468,666 (2023.05.24) Title: METHOD OF USING AN ARTIFICIAL INTELLIGENCE-POWERED WHOLE SLIDE IMAGE (WSI) ANALYSIS TO PREDICT TUMOR RESPONSE TO SUBSEQUENT IMMUNE CHECKPOINT INHIBITOR TREATMEN
 
Takao Fujisawa
Honoraria - Amelief; AstraZeneca; Merck; Merck Serono
 
Hiroshi Konishi
No Relationships to Disclose
 
Hidenori Kato
No Relationships to Disclose
 
Kaoru Oketani
No Relationships to Disclose
 
Mindi Styn
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
Patents, Royalties, Other Intellectual Property - University of Pittsburgh
 
Amy Lehman
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Tomasz Beer
Employment - Exact Sciences
Leadership - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences; Osheru; Osteologic
Consulting or Advisory Role - AstraZeneca
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Indivumed; Sumitomo Corp.
Research Funding - Bristol-Myers Squibb Japan (Inst); Caris MPI (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); Exact Sciences (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Miyarisan pharmaceutical (Inst); MSD (Inst); Natera (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Tomonori Yano
Consulting or Advisory Role - Olympus; Rakuten Medical
Speakers' Bureau - Meiji Seika Kaisha; Olympus
Research Funding - Fujifilm; HOYA Techonosurgical (Inst); Olympus; Rakuten Medical (Inst)